Complement Therapeutics
Edit

Complement Therapeutics

https://complementtx.com/
Last activity: 10.11.2023
Categories: ProductPlatformNewsLegalTechInformationHealthTechDevelopmentBioTechUniversityResearch
Complement Therapeutics GmbH (CTx) is a German headquartered early-stage biotech focused on the research and development of novel therapeutics for complement-mediated diseases. CTx is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. CTx lead investigational product (CTx001) is being evaluated as a potential gene therapy for Geographic Atrophy, a leading cause of blindness.
Mentions
15
Persons
5
Location: United Kingdom, England, London
Total raised: $84.66M
Founders name: Richard Unwin; Simon J. Clark

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
18.04.2023Series A$79.07MForbion
23.02.2022Seed$5.59MForbion

Persons 5

DateFirst NameLast NameTitleLinkedInLocation
-SimonJ. ClarkCo-Founderlinkedin.c...-
-HarryKwongAssociate ...linkedin.c...-
-RafiqHasanChief Exec...linkedin.c...-
-MustafaMunye-linkedin.c...-
-RichardUnwinCo-Founderlinkedin.c...-

Mentions in press and media 15

DateTitleDescriptionSource
10.11.2023Complement Therapeutics Enrols First US Participant in the N...Munich, Germany. 9 November 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnol...seroba-lif...
09.11.2023Complement Therapeutics Enrols First US ParticipantComplement Therapeutics Enrols First US Participant in the Non-interventional i-GAIN Study of People...hadeanvent...
02.10.2023'The fundamentals are really strong': Why investors are stay...While the biotech bull market hasn’t charged back in 2023 as many had hoped, European-focused ventur...fiercebiot...
05.08.2023Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chi...Munich, Germany. 2 August 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog...seroba-lif...
11.05.2023Il mercato del Venture Capital ad aprile 2023Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle s...startup-ne...
08.05.2023London-based startups that raised over €10M in April 2023; 1...London’s startup ecosystem continues to flourish, attracting investors from around the globe and fos...siliconcan...
27.04.2023Complement Therapeutics appoints Dominic Moreland as Chief F...Complement Therapeutics appoints Dominic Moreland as Chief Financial Officer Complement Therapeutic...cic.vc/new...
18.04.2023Complement Therapeutics Secures €72 Million in Series A Fina...Munich, Germany. 17 April 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog...seroba-lif...
17.04.2023Complement Therapeutics Secures €72 Million in Series A Fina...Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Target...hadeanvent...
17.04.2023VCs 'Complement' European biotech with $79M for retinal AAV ...VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year Endpoints ...cic.vc/new...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In